Adderall (dextroamphetamine/racemic amphetamine)
Jump to navigation
Jump to search
Introduction
DEA-controlled substance: class 2.
Indications
- attention deficit, hyperactitivity disorder (ADHD)
- narcolepsy
Contraindications
Dosage
Tabs: 10 & 20 mg (double scored)
Adderall XR: (once a day) 10, 20, 30 mg.
Pharmacokinetics
elimination: liver
Adverse effects
- sudden death in pediatric patients taking Adderall XR[3]
More general terms
Components
References
- ↑ The Pharmacological Basis of Therapeutics, 9th ed. Gilman et al, eds. Permagon Press/McGraw Hill, 1996
- ↑ Prescriber's Letter 8(12):69 2001
- ↑ 3.0 3.1 FDA Medwatch http://www.fda.gov/medwatch/SAFETY/2005/safety05.htm#Adderall
Prescriber's Letter 12(3): 2005 Public Health Advisory for Adderall and Adderall XR Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=210306&pb=PRL (subscription needed) http://www.prescribersletter.com